Sangamo Therapeutics slides after $25 million stock sale
03/02/2026 14:27
** Shares of genomic medicine firm Sangamo Therapeutics SGMO.O slide 19% to $0.46 premarket
** SGMO announces pricing of $25 million stock sale at $0.4719 apiece
** Company sold 35.2 million shares and pre-funded warrants to purchase 17.8 million shares in the offering
** Proceeds from offering to be used for working capital and general corporate purposes
** Cantor and Wells Fargo Securities are joint book-running managers for offering
** Three of five brokerages rate the stock "buy" or higher and two "hold"; median PT $2 - data compiled by LSEG
** As of last close, SGMO shares down 35.2% YTD
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))